Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunoglobulin light chain nephropathies.

B C Sturgill, F L Tucker, W K Bolton

    Pathology Annual
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Excessive monoclonal light chain production causes kidney disease, known as light chain nephropathy. Different light chains (kappa and lambda) are linked to distinct kidney damage types, impacting diagnosis and treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The role of the nephrologist in ESRD/Pre-ESRD care: a collaborative approach.

    Journal of the American Society of Nephrology : JASN·2001
    Same author

    Pathogenesis of focal glomerulosclerosis.

    Nephron·2001
    Same author

    ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group.

    Kidney international·2000
    Same author

    Intravenous iron dextran treatment in predialysis patients with chronic renal failure.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2000
    Same author

    Treatment of glomerular diseases: ANCA-negative RPGN.

    Seminars in nephrology·2000
    Same author

    Improved urea reduction ratio and Kt/V in large hemodialysis patients using two dialyzers in parallel.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2000

    Area of Science:

    • Nephrology
    • Immunology
    • Pathology

    Background:

    • Monoclonal light chain overproduction can lead to various kidney diseases collectively termed light chain nephropathy.
    • Kappa and lambda light chains exhibit differential associations with specific renal pathologies, such as tubular dysfunction and amyloidosis, respectively.
    • The underlying physicochemical mechanisms for this differential pathology remain largely unexplained.

    Purpose of the Study:

    • To elucidate the distinct roles of kappa and lambda light chains in the pathogenesis of light chain nephropathy.
    • To highlight the clinical spectrum and diagnostic approaches for light chain nephropathy.
    • To emphasize the importance of renal biopsy in diagnosing these conditions.

    Main Methods:

    • Review of clinical presentations and pathological findings in patients with light chain nephropathy.

    Related Experiment Videos

  • Analysis of the association between specific light chain types (kappa vs. lambda) and renal lesions.
  • Utilization of electron microscopy and immunofluorescence studies on renal biopsies.

    • Main Results:

    • Kappa light chains are more frequently associated with tubular dysfunction and nodular nonamyloidotic glomerulosclerosis.
    • Lambda light chains are more commonly implicated in the development of amyloidosis.
    • Patients present with a range of renal manifestations, from mild proteinuria to nephrotic syndrome and renal failure.

    Conclusions:

    • Light chain nephropathy arises from plasma cell dyscrasias or multiple myeloma causing excessive monoclonal light chain production.
    • Distinct light chain types contribute to specific renal pathologies, necessitating tailored diagnostic and potentially therapeutic strategies.
    • Renal biopsy with advanced imaging techniques is crucial for accurate diagnosis and understanding the specific mechanisms of kidney damage.